Al-Mouqdad Mountasser M, Aljobair Fahad, Alaklobi Faisal Abduljabar, Taha Muhammed Yassen, Abdelrahim Adli, Asfour Suzan Suhail
Neonatal Intensive Care Unite, Hospital of Pediatrics, King Saud Medical City, Riyadh, Saudi Arabia.
Pediatric Infectious Department, Hospital of Pediatrics, King Saud Medical City, Riyadh, Saudi Arabia.
Int J Pediatr Adolesc Med. 2018 Sep;5(3):110-115. doi: 10.1016/j.ijpam.2018.08.003. Epub 2018 Sep 21.
To assess whether there is any association between prolonged duration of the first course of empirical antibiotic treatment for suspected neonatal sepsis and other factors including comorbidities, interventions, and adverse outcomes.
Neonatal sepsis is one of the main reasons of mortality among premature infants in Neonatal Intensive Care Unit (NICU). Therefore, commencing antibiotics treatment on admission plays a crucial role in reducing the complications of neonatal sepsis, however the arbitrary use of antibiotics holds many serious complications. In our study we investigated the complications of prolonged use of antibiotics in treating suspected early onset of sepsis.
This is a retrospective cohort study of infants of gestational age 32 weeks or less and with birth weight of 1500 g or less along with suspected neonatal sepsis admitted to our neonatal intensive care unit from July 2015 to June 2017. The study outcome measures were the association between the antibiotic treatment duration and maternal factors, gender, adverse outcomes, developmental factors, comorbid conditions, early-onset sepsis, and late-onset sepsis.
Of 295 premature infants, late-onset sepsis was associated with the duration of early empiric antibiotic use (n = 54/295), where 50 (92.6%) infants with LOS received the antibiotic treatment for more than 5 days ( < .001). Approximately 91.2% of those receiving the prolonged treatment had a positive blood culture result. Necrotizing enterocolitis was more prevalent in those with long duration of antibiotic treatment (95.1%). Among patients with the comorbid conditions patent ductus arteriosus (n = 123/295), intraventricular hemorrhage (n = 73/295), and periventricular leukomalacia (n = 25/295), 100 (81.3%), 60 (82.2%), and 21 (84%) of them, respectively, received prolonged treatment.
Prolonged administration of empiric antibiotics to infants with very low birth weight along with sterile cultures is associated with the adverse outcomes late-onset sepsis and necrotizing enterocolitis. However, no association with other adverse outcomes, namely, candidiasis or maternal factors, was found.
评估疑似新生儿败血症的初始经验性抗生素治疗疗程延长与其他因素(包括合并症、干预措施和不良结局)之间是否存在关联。
新生儿败血症是新生儿重症监护病房(NICU)中早产儿死亡的主要原因之一。因此,入院时开始使用抗生素治疗在减少新生儿败血症并发症方面起着关键作用,然而抗生素的随意使用会带来许多严重并发症。在我们的研究中,我们调查了长期使用抗生素治疗疑似早发型败血症的并发症。
这是一项回顾性队列研究,研究对象为2015年7月至2017年6月入住我们新生儿重症监护病房的胎龄32周及以下、出生体重1500g及以下且疑似新生儿败血症的婴儿。研究结局指标为抗生素治疗持续时间与母亲因素、性别、不良结局、发育因素、合并症、早发型败血症和晚发型败血症之间的关联。
在295例早产儿中,晚发型败血症与早期经验性抗生素使用时间有关(n = 54/295),其中50例(92.6%)晚发型败血症婴儿接受抗生素治疗超过5天(P <.001)。接受延长治疗的患者中约91.2%血培养结果呈阳性。坏死性小肠结肠炎在抗生素治疗时间长的患者中更为普遍(95.1%)。在患有动脉导管未闭(n = 123/295)、脑室内出血(n = 73/295)和脑室周围白质软化(n = 25/295)合并症的患者中,分别有100例(81.3%)、60例(82.2%)和21例(84%)接受了延长治疗。
对出生体重极低的婴儿长期使用经验性抗生素且培养结果无菌与晚发型败血症和坏死性小肠结肠炎等不良结局相关。然而,未发现与其他不良结局(即念珠菌病或母亲因素)有关联。